revenue $848.9M, net income -$15.0M. Surgery Partners Q2 2026: revenue +2.7%, operating income -9%, net loss widens 500%

Filed August 10, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 5, 2025 · ~2 min read

Key Changes

• high

  Operating income fell 9% to $102.1M while net loss widened 500% to -$15.0M (from -$2.5M), driven by larger below-the-line deductions (interest/tax/NCI) not disclosed in detail. Net income remains below operating income, indicating the bottom-line deterioration is non-operational.

  MD&A: Operating Results & Notes: Income Statement verify on EDGAR →
• high

  Announced sale of two hospitals for ~$795M total consideration (including debt) in July 2026, subject to physician approvals and closing adjustments; final net cash proceeds not yet estimable. Material portfolio restructuring post-quarter.

  Notes: Subsequent Events verify on EDGAR →
• high

  Cost of revenues rose 130 basis points to 77.6% of sales (from 76.3%), driven by high-acuity procedures and increased hospital provider taxes. Adjusted EBITDA fell 2.9% to $125.2M, reversing prior year's 9.0% growth.

  MD&A: Cost of Revenues & Adjusted EBITDA verify on EDGAR →